Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Brain Behav Immun. 2020 Sep 20;90:353–363. doi: 10.1016/j.bbi.2020.09.012

Fig. 3.

Fig. 3.

CSF dopamine (panel A) and homovanillic acid (panel B) levels significantly moderate the association between HIV and depressive symptoms. Region of significance analyses estimate that HIV+ individuals have significantly higher depressive symptoms than HIV− individuals only when concentrations of dopamine and homovanillic acid fall within the lower half of their respective distributions (dopamine z ≤ 0.11; homovanillic acid z ≤ 0.06).